Risk of death in cystic fibrosis patients with severely compromised lung function

Chest

Volumn 113, Issue 5, 1998, Pages 1230-1234

  Milla, Carlos E ^a,b   Warwick, Warren J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Box 742 ^*  (United States)

Author keywords

Cystic fibrosis; Lung transplantation; Pulmonary function; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CYSTIC FIBROSIS; DEATH; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; LIFE EXPECTANCY; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL;

EID: 0031950258     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.5.1230     Document Type: Article

References (21)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122:1-9
2. Warwick WJ, Pogue RE, Gerber HU, et al. Survival patterns in cystic fibrosis. J Chron Dis 1975; 28:609-22
3. Cystic Fibrosis Foundation Patient Registry. 1995 annual data report. Bethesda, Md, September 1996
4. Wagener JS, Taussig LM, Burrows B, et al. Comparison of lung function and survival patterns between cystic fibrosis and emphysema or chronic bronchitis patients. In: Sturgess JM, ed. Perspectives in cystic fibrosis: proceedings of the Eighth International Congress on Cystic Fibrosis. Mississauga: Ontario Imperial Press, 1980; 236-45
5. Morrison D, Maurer JR, Grossman RF. Preoperative assessment for lung transplantation. Clin Chest Med 1990; 11: 207-15
6. Cremona C, Higenbottam T, Wallwork J. Transplantation for end-stage lung disease. Respiration 1991; 58(S1):22-29
7. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326: 1187-91
8. de Leval MR, Smyth R, Whitehead B, et al. Heart and lung transplantation for terminal cystic fibrosis. J Thorac Cardiovasc Surg 1991; 101:633-42
9. Kotloff RM, Zuckerman JB. Lung transplantation for cystic fibrosis: special considerations. Chest 1996; 109:787-98
10. Corey M, McLaughlin FJ, Williams M, et al. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41:583-91
11. Budd JR, Warwick WJ, Wiclinski CL, et al. A medical information relational database system. Comp Biomed Res 1988; 21:419-33
12. Regelmann WE, Elliott GR, Warwick WJ, et al. Reduction of sputum Pseudomonas aeruginosa density by antibiotics im proves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 1990; 141:914-21
13. Warwick WJ. Pulmonary function in healthy Minnesota children. Minn Med 1977; 60:135-40
14. Littell RC, Milliken GA, Stroup WW, et al. SAS system for mixed models. Cary, NC: SAS Institute Inc, 1996
15. Renzetti AD, McClement JH, Litt BD. Veterans Administration cooperative study of pulmonary function: III. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med 1966; 41:115-29
16. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease. N Engl J Med 1969; 280:397-404
17. Burrows B, Earle RH. Prediction of survival in patients with chronic airway obstruction. Am Rev Respir Dis 1969; 99: 865-71
18. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. Am Rev Respir Dis 1979; 119:895-902
19. Bishop JM, Cross KW. Physiological variables and mortality in patients with various categories of chronic respiratory disease. Bull Eur Physiopathol Respir 1984; 20:195-500
20. Corey M, Levison H, Crozier D. Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis 1976; 114:1085-92
21. Jedlicka-Köbler I, Götz M. Should transplantation be approached earlier than medically justified? Pediatr Pulmonol 1993; S9:274